T control of cell proliferation and differentiation, and its abnormal expression has been associated with many naturally occurring neoplasms.'x2 Repression of c-myc, expressed in proliferating cells, is required for terminal differentiation of many cell type^.^-^
We have shown that continuous, deregulated expression of c-myc in the myeloblastic leukemic M1 cell line blocks terminal myeloid differentiation induced by either interleukin-6 (IL-6) or leukemia inhibitory factor (LIF) at an intermediate stage in the progression from immature blasts to mature macrophages, precisely at the point in time when cmyc is normally s~ppressed.~ Evidence strongly suggests that c-myc is a transcription factor"; which genes are regulated by c-myc to control differentiation has not been determined.
To understand how deregulated c-myc interrupts the developmental program of myeloid differentiation, which will also increase our understanding of normal cell maturation, we have established M 1 mycer cell lines. The chimeric mycer transgene is composed of the hormone-binding domain of the &estradiol receptor fused to the carboxy terminus of the c-myc coding region; its function is dependent on 6-estradiol in the culture medium and not de novo protein synthesis, thereby allowing for precise regulation of c-myc activity.
In this work, we show that, for M 1 mycer cells, the block in terminal differentiation coupled to growth arrest, which culminates in programmed cell death (apoptosis), is dependent on the presence of ,&estradiol in the culture medium. By manipulating the function of the mycer transgene, it is shown that there is a small window of time when changes take place during the developmental program that preclude c-myc from having any detectable effect on terminal differentiation. Thus, M 1 mycer cell lines provide a powerful tool to increase our understanding of the role of c-myc in normal myelopoiesis and in leukemogenesis, while also providing a strategy to clone c-myc target genes.
MATERIALS AND METHODS
The differentiation competent murine M 1 myeloid leukemic cell line and M 1 myc2 were previously described.' Cells were cultured in Dulbecco's modified Eagle's medium (DMEM; GIBCO, Grand Island, NY) and 10% horse serum at 37°C in a hu- midified atmosphere with 10% C02. Cells were seeded at densities as indicated (0. I to 0.2 X IO6 for 3 to 4 days in culture); for RNA extraction using cells treated for less than 3 days, cell concentrations were adjusted so that final densities were greater than 0.25 X IO6 when harvested. Viable cell numbers were determined by trypan blue dye exclusion, with counting in a hemocytometer. M I mycer transfectants were maintained in phenol red free DMEM-21 (GIBCO) containing 10% dialyzed horse serum. M 1 and M Imyc2 cells were maintained in the same culture conditions when used as controls. PA317 (American Type Culture Collection, Rockville, MD),13 a viral packaging cell line, was maintained in DMEM and 10% fetal bovine serum (FBS). Brief selection in HAT medium was periodically performed to select for cells retaining the packaging function.
Purified human recombinant IL-6 (rIL-6) (0.5 mg/mL) was a gift from Dr L. Souza (Amgen, Inc, Thousand Oaks, CA) and was used at a concentration of 100 ng/mL. Purified murine LIF ( IO6 U/mL; obtained from GIBCO-BRL, Gaithersburg, MD) was used at a concentration of 200 U/mL. @-Estradiol was obtained from Sigma (St Louis, MO) and used at 2 pmol/L. M I cells were transfected via electroporation (BioRad Gene Pulsor; BioRad, Richmond, CA) with pAc.mycer or ~Ac,'.'~ linearized by digestion with EcoRI, and transfectants were selected for resistance to geneticin (G4 I8 sulfate; GIBCO) as described. ' Virus was generated from the plasmid forms of retroviral vectors pMV7I5 and pMV7.mycer (obtained from J. was used to infect M I cells.'6 Selection for infected cells by resistance to G4 I8 was the same as for transfectants.
Assays Jor diflerentiation associated properties, Fc and C3
receptors were assayed as previously described.'*'7 Morphologic differentiation was determined by counting at least 300 cells on
May-Griinwald-Giemsa-stained cytospin smears and scoring the proportion of immature blast cells, cells at intermediate monocyte stages of differentiation. and mature macrophages.'." DNA fragmentation. indicative of apoptosis, was determined by a modification of a procedure described previously'* in which, after lysis of cells and treatment with proteinase K. samples were treated with RNAase A. Five micrograms of the purified sample was fractionated on a 2% agarose gel.
General recombinant DNA techniques, expression vectors. and DNA probes. Plasmid preparations. restriction enzyme digestions, DNA fragment preparations, and agarose gel electrophoresis were as described before.'." Probes for murine c-myc. c-myh. and lyzozyme were the same as used previ~usly'.~.'~; the murine max.
also called myn. was obtained from E. Ziff and G. Prendergast (NYU Medical Center, New York, NY)." The ER probe was obtained by excision from the pMV7.mycer vector. DNA for probes was labeled by random priming to a specific activity equal to or greater than IO9 cpm/pg." To construct the pAc.mycer expression vector, the mycer fragment was excised from pMV7.mycer by EcoRl and blunt end ligated into the Hindlll site of pHb APr-Ineo" so that mycer was under control ofthe &actin gene promoter. RNA extraction. Northern blotting, and hybridization. RNA was extracted by the method of Chomczynski and Sacchi" using guanidinium thiocyanate. Total RNA (5 pg/lane) was electrophoresed on I% agarose formaldehyde gels. Northern blots, using Duralone-UV membranes (Stratagene, La Jolla, CA), were prepared, and UV cross-linked (Stratalinker, Stratagene) before baking. Hybridization and washing conditions and stripping blots of probe to rehybridize were performed as described previ~usly.'~ Western blotting Extracts of total proteins were prepared by resuspending cell pellets at a final concentration of 107/mL in lysis buffer(2X phosphate-buffered saline [PBS], 1% NP-40.0.5% sodium deoxycholate, 0. I% sodium dodecyl sulfate (SDS), I mmol/L EDTA, IO pglmL leupeptin. IO pg/mL chymostatin, 100 pg/mL phenylmethylsulfonyl fluoride [PMSF]). ARer incubation for I5 minutes on ice, DNAse I (50 pglmL) was added and samples were kept on ice for an additional 30 minutes. Four volumes ofcold acetone were added and samples were put at -2OOC. The protein precipitate was pelleted and dissolved in SDS-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer. Extracts from equal cell numbers were fractionated on IO% SDS-PAGE gels. Resolved proteins were transferred to Immobilon-P membrane (Millipore, Bedford. MA) using the Trans-blot (BioRad) apparatus at 50 V for 18 hours. To block nonspecific sites, the filter was incubated in PBS (pH 8.3) containing 5% bovine serum albumin (BSA) for 2 hours at room temperature. Blots were probed with 150 dilution of murine anti-c-myc antibodies (OM-I 1-904; Cambridge Research Biochemicals, Wilmington, DE) for 2 hours at room temperature in PBS (pH 7.2). 0.5% BSA, and 0.5% Tween 20. After rinsing blots three times in PBS containing 0.5% Tween 20. blots were incubated for 30 minutes at room tem-
RESULTS
c-myc protein in MI cells ajer IL-6 induction of terminal diferentiation. In a previous study, ' (Fig I) .
Establishment of MI cell lines expressing the mycer transgene. To regulate the activity of c-myc during myeloid differention, M 1 cell lines were established that contained the mycer transgene, in which the hormone-binding domain of the @-estradiol receptor is fused to the coding region of the human c-myc cDNA. The @-estradiol-binding domain confers hormone dependence on the function of the chimeric myc protein.
M I mycer cell lines were established by either transfecting with the pAc.mycer plasmid or infecting with the pMV7.mycer retroviral vector. Transfectants/infmnts were selected for resistance, conferred by the Neo' gene, to the drug geneticin (G4 18). In addition, M I neo cell lines, obtained after transfection with pAc or infection with pMV7, were established as controls. Analysis of the RNA from five Mlmycer cell lines obtained using pAc.mycer and five M I mycer cell lines using pMV7.mycer shows a @-estradiol receptor (ER) hybridizing transcript, corresponding in size to the expected size of the mycer transcript, not present in M I cells (Fig 2) .
The mycer transgene blocks terminal myeloid direrentiation in the presence of @-estradiol. All the cell lines expressing similar levels of mycer transcripts (Fig 2; clones 3,6, I I , I3,20,52, and 55) exhibited a similar phenotype. Data will be shown for the M 1 mycer-6 cell line, induced to undergo terminal differentiation with IL-6. Results obtained using LIF or conditioned medium from lungs (LUCM) as differentiation inducers were similar to those obtained using IL-6 (data not shown). The 6 MI neo cell lines analyzed behaved the same as the parental M I cell line (data not shown).
Mlmycer-6 cells were induced to undergo terminal differentiation with IL-6 in the presence or absence of Pestradiol. In all cases, the cells continued to express mycer transcripts (Fig 3) .
In the absence of &estradiol, IL-6-treated M 1 mycer-6 cells responded like MI cells, undergoing terminal differentiation (Fig 4A and Table I ), growth arrest (Table I) , and programmed cell death (apoptosis), characterized by DNA fragmentation (Fig 4B) and apoptotic morphology (data not shown). Induction of Fc and C3 receptors (Table I) , early myeloid differentiation markers, and lysozyme transcripts (Fig 3) . a late differentiation marker, and the early suppression of c-myh and c-myc transcripts (Fig 3) were observed: these responses to IL-6 have been previously reported for M I
In addition, downregulation of transcripts of m a , the molecular partner of c-myc,'o.m was detected after treatment of M 1 mycer-6 ( Fig  3) and MI (data not shown) with IM. In contrast to the results obtained in the absence of Bestradiol, when M I mycer-6 cells were treated concommitantly with IL6 and &estradiol, no mature cells were detected, but rather cells progressed only as far as the intermediate morphologic stage (Fig 4A and Table I) , reminiscent of the results reported for M I myc cell lines' (Table I) . These cells were not growth arrested (Table I) , did not undergo apoptosis (Fig 4B) , and failed to express lysozyme (Fig 3) .
However, endogenous c-myc and c-m-vh expression were suppressed (Fig 3) . as observed for M I myc cells3 (Fig 5) . The expression of max also was suppressed, although not to the level observed in the absence of @-estradiol (Fig 3) . Fc recep tors were induced to normal levels: however, C3 receptor induction was markedly inhibited, as seen with MI myc cells (Table I) . Thus, in the absence of Destradiol, Mlmycer cells responded like MI cells to IL-6, and in the presence of &es-tradiol responded like M I myc cells (Fig 5) .
--P-estradiol 2). M1 mycer-6 (lanes 3 and 4) . and M l mycer-6 plus fl-estradd (lanes 5 and 6). Cells were seeded at 0.1 X 106/mL, after 4 days were reseeded at the same concentration, and hm"ted after 7 days for DNA extraction. DNA extraction and electrophoresis were as described in Materials and Methods. Lanes 1. 3, and 5 were without IL-6; lanes 2,4, and 6 were with IL-6. IL-6 was used at 100 ng/mL; @-estradiol was used at 2 pmol/L. Cells were seeded at a density of 0.1 X 1 Os.
t Determined 4 days after the cells were seeded. All values represent the mean of three independent determinations with standard deviations up to 15%.
The differentiation block mediated by c-myc was reversible. M 1 mycer-6 cells treated concommitantly with IL-6 and P-estradiol for 3 days, where differentiation was blocked at an intermediate stage, followed by removal of P-estradiol from the culture medium, underwent terminal differentiation. Cells expressing extremely high levels of the mycer transgene (clones 54, 57, and 58; Fig 2B) behaved like Mlmyc in the presence or absence of &estradiol, not exhibiting a conditional block.
In conclusion, M 1 mycer cells were conditionally blocked for terminal differentiation, growth arrest, and apoptosis, where the block was dependent on the presence of @-estradiol in the culture medium.
Efect of activating c-myc at diferent stages in the progression from immature blasts to mature macrophages. Having the M 1 mycer cell lines, in which the functional product of the mycer transgene is conditional on the presence of &estradiol, enabled us to ascertain the crucial times when inappropriate expression of c-myc blocked terminal differentiation and to determine whether activation of c-myc had any effect on differentiated cells.
M 1 mycer-6 cells were induced to differentiate with IL-6, and at various times &estradiol was added to the culture medium. It can be seen that, although endogenous c-myc is suppressed by 18 hours after the induction of differentiation (Fig I) , activating c-myc as late as 30 hours after induction effectively blocked differentiation at the intermediate stage (Fig 6 and Table 2 ). However, activating c-myc 40 hours or later had no effect on terminal differentiation, growth arrest, and apoptosis. By 40 hours, the differentiation program had proceeded to a point at which IL-6-treated M1 cells were no longer sensitive to any effects due to c-myc; the differentiation program proceeded and no change was detectable in mature Abbreviations: BI, blast; Int, inter; Mat, mature.
Cells were seeded at a density of 0.1 X los, and 11-6 (at 100 ng/ mL) was added immediately. @-Estradiol (at 2 pmol/L) was added at indicated times. @-Estradiol was added at intervals before 30 hours, with results similar to 30 hours, and at intervals after 40 hours and up to 72 hours, with results similar to 40 hours. t Determined 4 days after cells were seeded.
minal differentiation program switched from being dependent on c-myc suppression to becoming c-myc suppression independent. Activation of c-myc had no apparent effect on mature macrophages, in contrast to the observation that activation of v-myb causes mature myeloid cells to acquire an immature p h e n~t y p e .~~ M lmycer cell lines provide a powerful tool to better understand the role of c-myc in the myeloid developmental program, as the mycer chimeric transgene also would do in other differentiating systems dependent on c-myc suppression. Identifying c-myc target genes is essential towards understanding how deregulated c-myc blocks differentiation, leading to the development of leukemias?6 The use of conditional Mlmycer cell lines provides a strategy to clone c-myc target genes regulating myeloid cell growth and differentiation.
